Anti-NAT2 antibody - C-terminal (ab135630) at 1/100 dilution + Mouse kidney tissue lysate at 35 µgdeveloped using the ECL technique
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human hepatocarcinoma tissue labelling NAT2 with ab135630 at 1/50 dilution followed by peroxidase-conjugated secondary antibody and DAB staining.
All lanes : Anti-NAT2 antibody - C-terminal (ab135630) at 1/100 dilutionLane 1 : 293 cell lysate, non-transfected Lane 2 : 293 cell lysate, transiently transfected with the NAT2 geneLysates/proteins at 2 µg per lane.developed using the ECL technique
Flow cytometric analysis of HepG2 cells labelling NAT2 with ab135630 at 1/10 dilution (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibody was used for the analysis.